Invivyd, Inc. (IVVD)
1.11
+0.02
(+1.83%)
USD |
NASDAQ |
May 21, 16:00
1.12
+0.01
(+0.90%)
After-Hours: 19:59
Invivyd EPS Diluted (Quarterly) : -0.1337 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MannKind Corp. | -0.0539 |
| Altimmune, Inc. | -0.1813 |
| Cellectar Biosciences, Inc. | -1.333 |
| Karyopharm Therapeutics, Inc. | -1.236 |
| REGENXBIO, Inc. | -1.718 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.40M |
| Revenue (Quarterly) | 13.74M |
| Total Expenses (Quarterly) | 55.14M |
| Enterprise Value | 151.49M |
| Gross Profit Margin (Quarterly) | 88.76% |
| Profit Margin (Quarterly) | -301.2% |
| Earnings Yield | -32.14% |
| Normalized Earnings Yield | -32.13 |